About Us
Our Story
Science
Pipeline
Type 1 Diabetes
Heart Failure
Chronic Kidney Disease
SGLT1/2 Inhibition
Mechanism of Action
News and Investors
Press Releases
Industry Dynamics
Contact

SGLT1/2 Inhibitor: Provide Full Cardiac Protection

2021-12-21 00:00:00
Return

ABUIABAEGAAgtYOGjgYonJnNyQcw3ws44Qg!700x700.png

ABUIABAEGAAgvoOGjgYo24qgBTC0CzijCA!700x700.png

1667368888727833.png

Previous:急性肝炎会转为慢性吗 出现这些症状需要留意
Next:欧洲糖尿病年会发布研健YG1699在糖尿病肾病领域的最新研究成果

More news

  • Lexicon Preparing to Resubmit Sotag...

  • Positive Results of a YG1699 Phase ...

  • Does SGLT1 Inhibition Add to the Be...

© 2022 YOUNGENE ALL RIGHTS RESERVED    PHONE:021-50772330    E-MAIL:jacky.li@youngene.com   Technical support:jjcloudservice